Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Alladapt announces $119M institutional financing to support ongoing clinical development

Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, announced today the closing of a $119 million...

ResApp stock returned from trading halt, down 29%

The ResApp Health Ltd share price has returned from its trading halt and taken a tumble. In morning trade, the digital health company’s shares...

Merck looks to acquire Seagen

Pharmaceutical giant Merck is exploring a possible purchase of biotech company Seagen, according to The Wall Street Journal. No deal is imminent, sources told the...

Abbott infant formula plant closes again after severe storms and flooding, shares plummet

Abbott Laboratories (ABT.N) has stopped production of the EleCare specialty baby formula at its plant in southwestern Michigan after thunderstorms and heavy rains flooded...

GSK shares lost 3.85% in the last month

In the latest trading session, GlaxoSmithKline (GSK) closed at $41.64, marking a -0.74% move from the previous day. This move was narrower than the...

Geno and Unilever launch $120 million venture to expand alternative to palm oil and fossil fuels

Genomatica (Geno), a leader in biotech and sustainability and Unilever have launched a venture to scale and commercialize alternatives to palm oil and fossil...
spot_img

Expert Articles

spot_img